Johnson & Johnson declined to comment on a report that the Food and Drug Administration (FDA) said would throw away 60 million doses of the COVID-19 vaccine, which is made in a Maryland facility at have a problem due to concerns about contamination The report, published by the New York Times, cited people familiar with the situation and came as the FDA announced it had approved two vaccines being manufactured at the Emergent BioSolutions facility in Baltimore, but found that “many other batches had not been available.” ” Not suitable for use
The FDA also noted in a press release posted on Friday that “Additional kits are still under review and the agency will notify the public once the review is complete,”; the agency said. “Not yet ready to include the Emergent BioSolutions plant in Janssen EUA as a licensed facility” and continues to “work through a number of issues.” with the management of Janssen and Emergent BioSolutions.”
CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGE.
A Johnson & Johnson spokesman declined to comment to Fox News on the matter.
This is an evolving story. Please keep coming back to check for updates.